Myoderm Joins SCRS as Global Impact Partner
The Society for Clinical Research Sites (SCRS) announced a two-year collaboration with Myoderm, a sourcing, distribution, and management of comparator drugs and other pharmaceutical products and supplies for clinical research organization.
The Society for Clinical Research Sites (SCRS) announced a two-year collaboration with Myoderm, a sourcing, distribution, and management of comparator drugs and other pharmaceutical products and supplies for clinical research organization. Myoderm will participate as a Global Impact Partner (GIP) and align with sponsors, CROs and other industry solution providers who share an ongoing commitment to promoting site sustainability across the clinical trials landscape.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
